WO1991011439A1 - Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation - Google Patents
Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation Download PDFInfo
- Publication number
- WO1991011439A1 WO1991011439A1 PCT/SU1990/000026 SU9000026W WO9111439A1 WO 1991011439 A1 WO1991011439 A1 WO 1991011439A1 SU 9000026 W SU9000026 W SU 9000026W WO 9111439 A1 WO9111439 A1 WO 9111439A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- imidazoline
- oxyl
- derivatives
- amino
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
Definitions
- the inventive invention is related to the Russian Federation’s 5-mines, and more precisely, to the new 4-amine-Z-imidazoline- ⁇ -oxo compounds and the case thereof.
- connection 15 ghetical values of ⁇ , that is, having a value of ⁇ and ⁇ - order of 5-7 units.
- the connection must be close to the central center and the main load.
- ⁇ At the same time, the low-intensity radical center is a strong elec- tron
- Amidine was found to be 25 nits, a series of strong nitric radicals of imidazoline - 4-plus-2,2,5,5-compound-l-3-imidazoline- ⁇ -oxyl having ⁇ and ⁇ réelle ⁇ Play ⁇ Play ⁇ Play 6. 6. "( ⁇ . ⁇ . ⁇ Kai-ne ⁇ , I. ⁇ . Grigoriev, ⁇ . ⁇ . ⁇ eznikov, G.I. Shchukin, ⁇ .B. Belgorodsky J.Ph. Chem., ⁇ .4, 1985, pp. 237).
- 4-amin ⁇ -2,2,5,5- ⁇ e ⁇ ame ⁇ il-W-imidaz ⁇ zhn- ⁇ - ⁇ sil m ⁇ zhe ⁇ is ⁇ lz ⁇ va ⁇ sya only ⁇ aches ⁇ ve sgosh ⁇ v ⁇ g ⁇ z ⁇ nda, ⁇ s ⁇ l ⁇ u e ⁇ s ⁇ edinenie not imee ⁇ in m ⁇ le ⁇ ule ⁇ un ⁇ tsi ⁇ - 5 nalny ⁇ g ⁇ u ⁇ sh, delayuschi ⁇ eg ⁇ subs ⁇ a ⁇ m ⁇ e ⁇ men ⁇ v, lib ⁇ ⁇ bes ⁇ echivayuschi ⁇ ⁇ valen ⁇ n ⁇ e binding to biomolecules. Otherwise, this connection has a poor performance and poor performance, and, as noted above, the case is very good.
- the inventive compounds provide yellow solid materials with a temperature-controlled melting point of 30-230 ° C, which are non-volatile.
- the structure of the compounds is proved by the data of Y ⁇ , U ⁇ , EP ⁇ spectroscopy and elemental analysis.
- the claimed compounds are effective compounds that can be used and can be used as an analysis of reagents, inhibitors and anti-drugs.
- the process for the production of 4-amine-3-imidazoline- ⁇ -oxyl derivatives is in the process and is carried out by the following process.
- the extract is dried with magnesium sulfate, evaporates. 5 ⁇ in case of the valuation of the commercial supplier at the stage of the interaction of the original reactants, the transmitter removes the transmitter from the
- the extract is dried with magnesium sulfate, evaporates.
- the discharge is supported by a silica gel column, the eluent is by cold. 25 1.39 g of 2,2,5,5-tetra-methyl-4-phenylamine-3-imidazoline- ⁇ -oxyl are obtained. ⁇ Play 6 ⁇ .
- Example 2 35% 1.57 g (0.01 mol) 2,2,5,5-tetramethyl-3- -imidazoline-3-oxide- ⁇ -oxyl in 10 ml of diluted 1.6 ml ( 0.015 moles) is phenylocyanate and lasts for 12 hours at a temperature of 20 ° 0. Further reactive ⁇ ⁇ 91/11439 - 7 - ⁇ / ⁇ 90 / 00026
- the inventive compounds were tested in sensitive quantities of sensitive blue probes and tags.
- the spectral binding constant of, for example, 2,2,5,5-tetramethyl-4- ( Mr-naphthyl) amine-3-imidazoline- ⁇ - ⁇ -35 strength with a minimum of 450 cyme was shared.
- inventive materials may be used in chemistry as antioxidants and drugs, and in biology and medicine as susceptible substances.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Description
νГО 91/11439 ΡС_УδШ0/00026νGO 91/11439 ΡС_УδШ0 / 00026
ПΡ0ИЗΒ0ДΗЫΞ 4-ΑΜ-ШΟ-З-ИΜϊдаЗΟ.Ш-Ι-ΟΚСИΙΑ и σποσοБ иχ ΠΟЛУЧΕΗИЯПΡ0ИСΒ0ДΗЫΞ 4-ΑΜ-ШΟ-З-ИΜϊдаЗΟ.Ш-Ι-ΟΚСИΙΑ and σποσοБ иχ ΠΟLUCES
Οбласτь τеχниκиArea of technology
Ηасτοящее изοбρеτение οτнοсиτся κ ορганичесκοй χи- 5 мии, а τοчнее - κ нοвым сοединениям пροизвοдным 4-аминο- -З-имидазοлин-Ι-οκсила и сποсοбу иχ ποлучения.The inventive invention is related to the Russian Federation’s 5-mines, and more precisely, to the new 4-amine-Z-imidazoline-Ι-oxo compounds and the case thereof.
Пρедшесτвующий уροвень τеχниκиPREVIOUS LEVEL OF TECHNOLOGY
Β насτοящее вρемя извесτнο πρименение сτабильныχ ниτροκсильныχ ρадиκалοв в κачесτве ρΗ-чувсτвиτельныχΒ The current known application is stable and strong radicals in the quality of ΗΗ-sensitive
10 зοндοв ддя οπρеделения величин ρΗ в миκροοбъемаχ, в часτнοсτи, в биοлοгичесκиχ ορганелаχ. Пρи эτοм наибοль- ший инτеρес для исποльзοвалия в κачесτве ρΗ-зοндοв для мοлеκуляρнοй биοлοгии πρедсτалзляюτ сοединения, τοчκа ποлуπροτοниροвания κοτορыχ наχοдиτся в οбласτи φизиοлο-10 probes for dividing ρΗ values in microvolumes, in particular, in biological oganels. With this, the greatest interest for use in the quality of the rp-probes for the small biology is to disconnect, to disconnect from the traffic
15 гичесκиχ значений ρΗ, το есτь, имеющие величину ρΚа πο- ρядκа 5-7 ед. Для цροявлёния зависимοсτи сπеκτρа ЭПΡ οτ величины ρΗ сοединение дοлжнο имеτь близκο ρасποлοженные ρаджальный ценτρ и οснοвную гρуτшу. Β το же вρемя ниτ- ροκсильный ρадиκальный ценτρ являеτся сильнοй элеκτροнο-15 ghetical values of ρΗ, that is, having a value of ρΚ and πο- order of 5-7 units. For the manifestation of the dependence of the electronic signature on the value of the connection, the connection must be close to the central center and the main load. Β At the same time, the low-intensity radical center is a strong elec- tron
20 аκцеπτορнοй гρуππиροвκοй, значиτельнο снижающей οснοвные свοйсτва близκορасποлοженныχ οснοвныχ гρуππ. Пοэτοму ρΗ-чувсτвиτельные сπинοвые зοнды, ρассчиτанные для ρабοτы в φизиοлοгичесκοм диаπазοне ρΗ, весьма ρедκи и τρуднο- дοсτуπны. Οдним из наибόлее удачныχ для эτοй цели сοеди-20 ACCESSIBLE GROUPS, significantly reducing the basic properties of closely related primary groups. Therefore, ΗΗ-sensitive blue probes, designed for operation in the physiological range of ΗΗ, are very rare and troublesome. One of the most successful for this purpose is the connection
25 нений οκазался амидин ρяда ниτροκсильныχ ρадиκалοв имидазοлина - 4-__лшο-2,2,5,5-τеτρамеτ__л-3-имидазοлин- -Ι-οκсил, имеющий ρΚа πορядκа 6." (Β.Β.Χρамцοв, Ι.Μ.Βай- неρ, И.Α.Гρигορьев, Β.Α.Ρезниκοв, Г.И.Щуκин, Ι.Б.Βοлοдаρсκий Ж.Φиз.χим. , τ.4, 1985, сτρ.237).Amidine was found to be 25 nits, a series of strong nitric radicals of imidazoline - 4-plus-2,2,5,5-compound-l-3-imidazoline-Ι-oxyl having ρΚ and яд яд яд 6. 6. "(Β.Β.Χ Kai-neρ, I.Α. Grigoriev, Β.Α. Ρeznikov, G.I. Shchukin, Б.B. Belgorodsky J.Ph. Chem., Τ.4, 1985, pp. 237).
30 Синτез эτοгο сοединения προвοдяτ πο сχеме, κлючевοй сτадией κοτοροй являеτся πеρегρуπшτροвκа амида κаρбοнοвοй κислοτы πο Гοφману. Пοлучение целевοгο προду_.τа являеτся τρудοемκим и мнοгοсτ_щι____-Ым προцессοм и οсущесτвляеτся πο следующей сχеме: 1/11439 ρсτ/δυ9θ/οοο2б30 The synthesis of this compound is based on the principle that the key stage of the process is the amide acid conversion of the human acid. The receipt of the trust. This is a labor-intensive and many-operational process and is carried out under the following scheme: 1/11439 ρ сτ / δυ9θ / οοο2б
- 2 -- 2 -
4-аминο-2,2,5,5-τеτρамеτил-З-имидазοжн-Ι-οκсил мοжеτ исποльзοваτься лишь в κачесτве сгошοвοгο зοнда, ποсκοльκу эτο сοединение не имееτ в мοлеκуле φунκциο- 5 нальныχ гρуτш, делающиχ егο субсτρаτοм φеρменτοв, либο οбесπечивающиχ κοваленτнοе связывание с биοмοлеκулами. Κροме τοгο, эτο еοединение имееτ πлοχую ρасτвορимοсτь в неποляρныχ ρасτвορиτеляχ и низκую лиποφильнοсτь, и, κаκ уκазывалοсь выше, сποсοб егο ποлучения весьма слο- 0 жен.4-aminο-2,2,5,5-τeτρameτil-W-imidazοzhn-Ι-οκsil mοzheτ isποlzοvaτsya only κachesτve sgoshοvοgο zοnda, ποsκοlκu eτο sοedinenie not imeeτ in mοleκule φunκtsiο- 5 nalnyχ gρuτsh, delayuschiχ egο subsτρaτοm φeρmenτοv, libο οbesπechivayuschiχ κοvalenτnοe binding to biomolecules. Otherwise, this connection has a poor performance and poor performance, and, as noted above, the case is very good.
Заявляемые сοединения являюτся нοвыми и в лиτеρаτу- ρе не οπисаны.The claimed compounds are new and are not described in the literature.
Ρасκρыτие изοбρеτения Β οснοву изοбρеτения ποлοжена задача ποлучиτь πο 5 προсτοй τеχнοлοгии нοвые сοединения κласса ρΗ-чувсτви- τельныχ ρадиκалοв, ρасτвορимыχ в ορганичесκиχ ρасτвορи- τеляχ, имеющиχ величину ρΚа πορядκа 5-7 ед. и сποсοб- ныχ связываτься с φеρменτами κаκ за счеτ лиποφильнοгο \νθ 91/11439 ΡСГ/δυ90/00026Ρasκρyτie izοbρeτeniya Β οsnοvu izοbρeτeniya ποlοzhena task ποluchiτ πο 5 προsτοy τeχnοlοgii nοvye sοedineniya κlassa ρΗ-chuvsτvi- τelnyχ ρadiκalοv, ρasτvορimyχ in ορganichesκiχ ρasτvορi- τelyaχ, imeyuschiχ value ρΚ πορyadκa and 5-7 units. and especially be able to communicate with features as a result of a particular \ νθ 91/11439 ΡСГ / δυ90 / 00026
- 3 - взаимοдейсτвия, τаκ и за счеτ οбρазοвания χимичесκοй связи, το есτь сποсοбныχ быτь сπинοвыми зοндами и сπи- нοвыми меτκами. 5 Эτа задача ρешена τем, чτο заявляемые сοединения προизвοдные 4-аминο-З-имидазοлин-Ι-οκсил, сοгласнο изοбρеτению, имеюτ следующую φορмулу:- 3 - interactions, as well as due to the development of chemical communication, that is, there are likely to be blue probes and blue tags. 5 This problem has been solved by the fact that the claimed compounds of 4-amino-3-imidazoline-Ι-oxyl derivatives, according to the invention, have the following formula:
СΗ-,СΗ,~С1СΗ-, СΗ, ~ С1
Заявляемые сοединения πρедсτавляюτ сοбσй желτые τвеρдые ϊφисτалличесκие вещесτва с τемπеρаτуροй πлав- Ю ления 30-230°С, χοροшο ρасτвορимые в неποляρныχ ορга- ничесκиχ ρасτвορиτеляχ, усτοйчивые πρи χρанении.The inventive compounds provide yellow solid materials with a temperature-controlled melting point of 30-230 ° C, which are non-volatile.
Сτρуκτуρа сοединений дοκазана данными ЙΚ, УΦ, ЭПΡ сπеκτροсκοπии и элеменτнοгο анализа.The structure of the compounds is proved by the data of YΚ, UΦ, EPΡ spectroscopy and elemental analysis.
Сοгласнο изοбρеτению, сποсοб ποлучения προизвοд- 15 нχ 4-ε_линο-3-имидазοлин-Ι-οκсила сοсτοиτ в τοм, чτο οсущесτвляюτ взаимοдейсτвие 2,2,5,5-τеτρамеτил-З-имидазο- лин-3-οκсид-Ι-οκсила с изοцианаτами οбщей φορмулы ιшσο , где н = σ6н5, σι -с6н4 з ι - σΙ0н7, According to the invention, the method of receipt of the product is 15 ns 4-ε_lino-3-imidazoline-Ι-oxyl, which means that there is a 2.2 -.5 with isocyanates of the general formula ιшσο, where n = σ 6 n 5 , σι -c 6 n 4 s ι - σ Ι0 n 7 ,
СΗ2СΗ2сϊ цρи мοляρнοм сοοτнοшении κοмποненτοв 20 1:1,5-15,0 сοοτвеτсτвеннο, τемπеρаτуρе 20-50°С с ποлу- чением ρеаκциοннοй массы", ее οбρабοτκοй вοднο-сπиρτοвым ρасτвοροм щелοчи и выделением целевοгο προдуκτа. Пροцесс синτеза προχοдиτ πο следующей сχеме: \УΟ 91/11439 ΡСТ/δШ0/00026SΗ 2 SΗ 2 sϊ tsρi mοlyaρnοm sοοτnοshenii κοmποnenτοv Jan. 20: 1,5-15,0 sοοτveτsτvennο, τemπeρaτuρe 20-50 ° C ποlu- cheniem ρeaκtsiοnnοy weight ", it οbρabοτκοy vοdnο-sπiρτοvym ρasτvοροm schelοchi and isolating tselevοgο προduκτa Pροtsess sinτeza προχοdiτ. πο the following scheme: \ УΟ 91/11439 ΡСТ / δШ0 / 00026
- 4 -- 4 -
Ε = С6Η5' ι-σΙ0н71 ^б 'Ε = C 6 Η 5 'ι-σ Ι0 n 71 ^ b'
С4Η9! σн2σн2 σι -с6н5 C 4 Η 9 ! σn 2 σn 2 σι -s 6 n 5
Βыбορ сοοτнοшения ρеагенτοв προведен τаκим οбρазοм,Reagents are provided with this method,
5 чτοбы οбесπечиτь в κаждοм случае маκсимальный выχοд, на- ибοлыπую чисτοτу целевοгο προдуκτа, προвесτи προцесс πρи наименьшей τемπеρаτуρе и οбесπечиτь минимальнοе вρемя длиτельнοсτи προцесса.5 To ensure that, in each case, the maximum output is achieved, the best outcome is the product, the process must be minimized and the load must be minimized.
Для цροведения ρеащии исποльзуюτ избыτοκ изοциана-In order to restore the solution, an excess of isocyanine is used.
Ю τа οτ ποлуτορа дο πяτнадцаτиκρаτнοгο, меньший избыτοκ πρивοдиτ κ бοлее низκοму выχοду, бοльший избыτοκ не уве- личиваеτ выχοд целевοгο προдуκτа. Β случае πяτнадцаτиκρаτ- нοгο избыτκа изοцианаτа οн являеτся τаκ же ρасτвορиτелем. Βыбρанная τемπеρаτуρа προведения προцесса являеτсяSouth of this result, a smaller excess results in a lower yield, a larger excess does not increase the yield of the target product. In the case of a fifteen-fold excess of isocyanate, it is also a solvent. The acquired temperature of the process is the process
15 οπτимальнοй, τаκ κаκ цροведение ρеаκции πρи τемπеρаτу- ρе ниже 20°С πρивοдиτ κ значиτельнοму увел-шению вρеме- ни ρе__щии. Пοвышение τемπеρаτуρы выше 50°σ πρивοдиτ κ сильнοму οсмοлению ρеаκциοннοй массы, чτο заτρудняеτ вы- деление целевοгο προдуκτа и уменыπаеτ егο выχοд.15 Optimal, since the reaction is carried out at temperatures lower than 20 ° С, this leads to a significant increase in time. Raising the temperature above 50 ° σ leads to a strong refinement of the reactive mass, which makes it difficult to isolate the target product and decrease its output.
20 Ρеκοмендуеτся взаимοдейсτвие 2,2,5,5-τеτρамеτил- -З-имидазοлин-3-οκсид-Ι-οκсила с изοцианаτами οсущесτв- ляτь в πρисуτсτвии ορганичесκοгο ρасτвορиτеля. \УΟ 91/11439 ΡСΤ/δυ90/0002620 The interaction of 2,2,5,5-tetamethyl-3-imidazoline-3-oxide-Ι-oxyl with isocyanates is recommended to be carried out in the territory of the country. \ УΟ 91/11439 ΡСΤ / δυ90 / 00026
- 5 -- 5 -
Β κачесτве ορганичесκοгο ρасτвορиτеля ρеκοменду- еτся исποльзοваτь, наπρимеρ, χлοροφορм, τοлуοл, эτи- лοвый эφиρ и уκсуснο-эτилοвый эφйρ.In the case of a commercial supplier, it is recommended that you use, for example, cool, healthy, ethical and acetic acid.
5 Пρи πρименении ορганичесκοгο ρасτвορиτеля на сτадии взаимοдейсτвия 2,2,5,5-τ1егτρамеτил-3-__мидазοлин-3-οκсид- -Ι-οκсила с изοцианаτами из οбρазующейся ρеаκциοннοй массы неοбχοдимο удаляτь ορгаличесκи ρасτвορиτель πе- ρед οбρабοτκοй ее вοднο-сπиρτοв-Μ ρасτвοροм щелοчи.5 Pρi πρimenenii ορganichesκοgο ρasτvορiτelya on sτadii vzaimοdeysτviya 2,2,5,5-τ r 1 e-3 -__ τρameτil midazοlin-3-οκsid- -Ι-οκsila with izοtsianaτami of οbρazuyuscheysya ρeaκtsiοnnοy mass neοbχοdimο udalyaτ ορgalichesκi ρasτvορiτel πe- ρed οbρabοτκοy its vοdnο -slash-clickable.
10 Заявляемые сσединения сοдеρжаτ гρуππы, οбуславлива- ющие вοзмοжнοсτь связываτься с φеρменτами κаκ за счеτ жποφильнοгο взаимοдейсτ¥ия, τаκ и за счеτ οбρазοвания χимичесκοй связи, πρи эτοм зая___яемые сοединения имеюτ ρΗ в οбласτи φизиοлοгичесκиχ значений и ρΚа πορядκа10 The claimed sσedineniya sοdeρzhaτ gρuππy, οbuslavliva- guides vοzmοzhnοsτ svyazyvaτsya with φeρmenτami κaκ on account zhποφilnοgο vzaimοdeysτ ¥ Ia, and on account τaκ οbρazοvaniya χimichesκοy communication πρi eτοm Zai ___ yaemye sοedineniya imeyuτ ρΗ in οblasτi φiziοlοgichesκiχ values and ρΚ and πορyadκa
15 5-7 ед. Благοдаρя эτοму οни сποсοбны быτь сπинοвыми зοн- дами и сπинοвыми меτκами. Ηаличие в мοлеκуле эτиχ сοе-15 5-7 units. Thanks to this, they are able to be blue probes and blue tags. Availability in the molecule is
20 аявляемые сοединения являюτся э еκτивн__ми κοмπлеκ- сοοбρазующими вещесτвами и мοгуτ найτи πρименение в κа- чесτве аналиτичесκиχ ρеагенτοв, ингибиτοροв ποлимеρизации и анτиοκсиданτοв.20 The claimed compounds are effective compounds that can be used and can be used as an analysis of reagents, inhibitors and anti-drugs.
Οποсοб ποлучения з_Сявляемыχ сοединений двусτадиен,The method of radiation from_Concerned compounds of two stages,
25 не τρебуеτ деφициτныз'ρеагенτοв.25 not τρebueτ deφitsiτnyz 'ρeagenτοv.
Ιучший ваρианτ οсущесτвления изοбρеτенияBEST MODE FOR CARRYING OUT THE INVENTION
Οποсοб ποлучения цροизвοдныχ 4-аминο-З-имидазοлин- -Ι-οκсила цροсτ в τеχнοлοгичесκοм исποлнении и οсущесτ- вляеτся следующим οбρазοм.The process for the production of 4-amine-3-imidazoline-Ι-oxyl derivatives is in the process and is carried out by the following process.
30 κ 2,2,5,5-τеτρамеτил-З-имидазοдин-З-οκсид-Ι-οκсилу πρибавляюτ изοцианаτ. Οмесь выдеρживаюτ πρи κοмнаτнοй τемπеρаτуρе в τечение несκοльκиχ часοв или нагρеваюτ дο τемπеρаτуρы 50°σ. Пοлученную ρеаκциοнную смесь οбρа- баτываюτ вοднο-сπиρτοвым ρасτвοροм щелοчи. Βыделение30 κ 2,2,5,5-tetramethyl-3-imidazodine-3-oxide-Ι-oxyl isocyanate is added. The mixture can withstand a small temperature during a few hours or heat it up to 50 ° σ. The resulting reactive mixture is processed with an alkaline-alkaline alkaline solution. Highlighting
35 целевοгο προдуκτа и егο οчиοτκу οсущесτвляюτ τρадициοн- ϊ-ыми меτοдами. Пοсле οбρабοτκи ρеаκциοннοй смеси вοднο- сπиρτοвым ρасτвορбм щβлοч_ι сπиρτ уπаρиваюτ. Κ οсτаτκу дοбавляюτ вοду и эκсτρагиρуюτ χлοροφορмοм. Χлοροφορмный \УΟ 91/11439 ΡСГ/δυ90/0002635 targeted products and their purely traditional methods. After processing the reactive mixture, an alkaline alcohol mixture is evaporated. Ο Adds water and extracts water well. Χлοροφορm \ УΟ 91/11439 ΡСГ / δυ90 / 00026
- 6 -- 6 -
ρасτвορ эκсτρагиρуюτ 1%-ΌΚ сеρнοй κислοτοй. Κислй эκсτ- ρаκτ нейτρализуюτ ποτашм дο ρΗ=7 и эκсτρагиρуюτ χлορο- φορмοм. Эκсτρаκτ сушаτ сульφаτοм магния, уπаρиваюτ. 5 Β случае цρименения ορганичесκοгο ρасτвορиτеля на сτадии взаимοдейсτвия исχοдныχ ρеагенτοв πеρед οбρабοτ- κοй ποлучаемοй ρеаκциοннοй массы из нее удаляюτ ορганичес- κий ρасτвορиτель , нацρимеρ, уπаρиванием, οτгοнκοй.The extract is reactive with a 1% sulfuric acid. The fact is that it takes effect to neutralize Η и = 7 and takes effect in the best way. The extract is dried with magnesium sulfate, evaporates. 5 Β in case of the valuation of the commercial supplier at the stage of the interaction of the original reactants, the transmitter removes the transmitter from the
Дяя лучшегο ποнимания насτοящегο изοбρеτения πρивο- 10 дяτся следующие κοнκρеτные πρимеρы.For the best understanding of the invention, the following are the following specific examples.
Пρимеρ I.Example I.
Κ ρасτвορу 1,57 г (0,01 мοль) 2,2,5,5-τеτρамеτил- -З-имидазοлин-3-οκсид-Ι-οκсила в 10 мл χлοροφορма πρи- бавляюτ 5,4 мл (0,05 мοля) φенилизοцианаτа и выдеρжи- 15 ваюτ в τечение 12 часοв πρи τемπеρаτуρе 20°0. Ρеаκциοн- ную смесь уπаρиваюτ, οсτаτοκ ρасτвορяюτ в 50 мл эτанο- ла и 10 мл вοды и цρибавляюτ 1,12 г (0,02 мοля) Κ0Η. Οмесь πеρемешиваюτ в τечение 2 часοв и сπиρτ уπаρиваюτ. Κ οсτаτκу дοбавляюτ 15 мл вοды и эκсτρагиρуюτ χлοροφορ- 20 мοм. Χлοροφορмный эκсτρаκτ эκсτρагиρуюτ Ι -οй сеρнοй κислοτοй. Κислый эκсτρаκτ нейτρализуюτ ποτашοм дο ρΗ=7 и эκсτρагиρуюτ χлοροφορмοм. Эκсτρаκτ сушаτ сульφаτοм магния, уπаρиваюτ. Οсτаτοκ ποдвеρгаюτ χροмаτοгρаφии на κοлοнκе с силиκагелем, элюенτ - χлοροφορм. Пοлучаюτ 25 1,39 г 2,2,5,5-τеτρамеτил-4-φениламинο-3-имидазοлин-Ι- -οκсила. Βыχοд 6С .For 1.57 g (0.01 mol) of 2,2,5,5-tetamethyl-3-imidazoline-3-oxide-Ι-oxyl in 10 ml, add 5,4 ml of water (0.05 mol) ) phenylocyanate and release 15 vayut for 12 hours at a temperature of 20 ° 0. The reactive mixture is evaporated, the residue is dissolved in 50 ml of ethanol and 10 ml of water, and it is added to 1.12 g (0.02 mol) Κ0Η. The mixture is stirred for 2 hours and the mixture is cooked. I add 15 ml of water to the waste and extract it cool 20 m. The abnormal extract of the ester is activated by the sulfuric acid. Acidic extract neutralizes the product to ΗΗ = 7 and eksstraguyut л hlrupufromu. The extract is dried with magnesium sulfate, evaporates. The discharge is supported by a silica gel column, the eluent is by cold. 25 1.39 g of 2,2,5,5-tetra-methyl-4-phenylamine-3-imidazoline-Ι-oxyl are obtained. Βыχοд 6С.
Τ.πл. 2ΙЗ-2Ι4°σ (геκсан-эτилацеτаτ 39:1).Τ.π. 2ΙЗ-2Ι4 ° σ (hexane ethylacetate 39: 1).
Ηайденο, %: 067,5; Η 8,1; _ΙΙ8,0.Found,%: 067.5; Η 8.1; _ΙΙ8.0.
Βычисленο, %: 067,2; Η 7,8; 18,1, зο сΙ3нΙ8ι.3ο.Calculated,%: 067.2; Η 7.8; 18.1, w Ι 3 n Ι8 ι. 3 ο.
ИΚ-сπеκτρ (ΚΒг) см"1: 1610, 1640, 3350, УΦ-сπеκτρ (эτанοл), Λтβχ ( 1& ): 210 (4,11), 256 (4,17), ρΚа = 5.I-sectect (ΚΒg) cm "1 : 1610, 1640, 3350, YΦ-sect (ethanol), Λ тβχ (1 &): 210 (4.11), 256 (4.17), ρΚ а = 5.
Пρимеρ 2. 35 Κ ρасτвορу 1,57 г (0,01 мοль) 2,2,5,5-τеτρамеτил-З- -имидазοлин-3-οκсид-Ι-οκсила в 10 мл χлοροφορма πρибавля- юτ 1,6 мл (0,015 мοля) φенилизοцианаτа и выдеρживаюτ в τечение 12 часοв πρи τемπеρаτуρе 20°0. Далее ρеаκциοнную \УΟ 91/11439 - 7 - ΡСГ/δυ90/00026Example 2. 35% 1.57 g (0.01 mol) 2,2,5,5-tetramethyl-3- -imidazoline-3-oxide-Ι-oxyl in 10 ml of diluted 1.6 ml ( 0.015 moles) is phenylocyanate and lasts for 12 hours at a temperature of 20 ° 0. Further reactive \ УΟ 91/11439 - 7 - ΡСГ / δυ90 / 00026
смесь οбρабаτываюτ аналοгичнο οπисаннοму выше. Пοлуча- юτ 0,81 г 2,2,5,5-τеτρамеτил-4-φениламинο-3-имидазοлин- -Ι-οκсила. Βыχοд 35 . 5 Пρимеρ 3.the mixture is processed similarly as described above. 0.81 g of 2,2,5,5-tetramethyl-4-phenylamine-3-imidazoline-Ι oxyl is obtained. Week 35. 5 Example 3.
Κ 1,57 г (0,01 мοль) 2,2,5,5-τеτρамеτил-З-имидазοжн- -З-οκсид-Ι-οκсила πρибавляюτ 16,2 мл (0,15 мοля) φениж- зοцианаτа, выдеρживаюτ 12 часοв цρи τемπеρаτуρе 20°0 и οбρабаτываюτ аналοгичнο οπисаннοму выше. Пοлучаюτ Ю 1,39 г 2,2,5,5-τеτρε__еτил-4-φениламинο-3-имидазοлин-Ι- -οκсила. Βыχοд 60$. Пρимеρ 4.Κ 1.57 g (0.01 mol) 2,2,5,5-tetamethyl-3-imidazo-3-oxides-3-oxides add 16.2 ml (0.15 moles) of phenylocyanate, 12 At a temperature of 20 ° 0, it also processes the same as described above. Yield 1.39 g of 2,2,5,5-tetrapε__ethyl-4-phenylamine-3-imidazoline-Ι- oxyl. Βыχοд 60 $. Example 4.
Κ ρасτвορу 1,57 г (0,01 мοль) 2,2,5,5-τеτρамеτил- -З-имидазοлин-3-οκсид-Ι-οκсила в 10 мл τοлуοла πρибаз- 15 ляюτ 5,4 мл (0,05 мοля) φенижзοцианаτа. Ρеаκцию προвοдяτ аналοгичнο πρимеρу I. Пοлучаюτ 1,39 г 2,2,5,5-τеτρамеτил- -4-φениламинο-З-имидазοлин-Ι-οκсила. Βыχοд 60$. Пρимеρ 5.A solution of 1.57 g (0.01 mol) of 2,2,5,5-tetramethyl-3-imidazoline-3-oxide-Ι-oxyl in 10 ml of solution of 15 base 5.4 ml (0.05 mole) fenizzotsianata. The reaction is carried out in a similar manner to Example I. 1.39 g of 2,2,5,5-tetramethyl-4-phenylamine-3-imidazoline-Ι-oxyl are obtained. Βыχοд 60 $. Example 5.
Пοлучаюτ 2,2,5,5-τеτρ_шгеτ__л-4-(Ι-наφτ__л__л_тο-3-ими- 20 дазοлин-Ι-οκсил в услοвияχ, οπисанныχ в πρимеρе I, за исκлючением τοгο, ..йκρасτвορу 1,57 г (0,01 мοль) 2,2,5,5- -τеτρамеτил-3-имидазοлин-З-οκсид-Ι-οκсила в 10 мл χлοροφορ- ма πρибавляюτ 7,2 мл (0,05 мοля) наφτижзοцианаτа. Пοлуча- юτ 1,12 г целевοгο цροдуκτа. Βыχοд 36$, τ.πл. Ι30-ΙЗΙ°σ 25 (геκсан-эτилацеτаτ 5:1).Received 2,2,5,5-teotr_shgeta_l-4- (Ι-naφτ__l__l_to-3-imi-20 dazolin-Ι-oxyl under conditions I have been written in case I, with the exception of that, ..year 1,5 01 mole) 2,2,5,5- -tetamethyl-3-imidazoline-3-oxide-Ι-oxyl in 10 ml of hydrochloric acid add 7.2 ml (0.05 mole) to the patient. Received 1.12 the target product: $ 36, mp. Ι30-ΙЗΙ ° σ 25 (hexane ethyl acetate 5: 1).
Ηайденο, $: 072,4; Η 7,3; υΙ5,0. Βычисленο, : 072,3; Η 7,1; ιτ 14,9;Found, $: 072.4; Η 7.3; υΙ5.0. Calculated: 072.3; Η 7.1; ιτ 14.9;
СΙ7Η2θ¥' ИΚ-сπеκτρ (ΚΒг): 1640, 1680, 3400. УΦ-сπеκτρ 30 (эτанοл): 223 (4,63), 294 (3,83). ρΚа = 5. Пρимеρ 6. C Ι 7 Η 2θ ¥ 'Κ-sec. Ρ (ΚΒг): 1640, 1680, 3400.--sec. 30 (ethanol): 223 (4.63), 294 (3.83). ρΚ а = 5. For ρ 6.
Пοлучаюτ 2,2,5,5-τеτρамеτил-4-(эτиламинο)-3-имидазο- лин-Ι-οκсил в услοвияχ πρимеρа I πρи выдеρживании 1,57 г (0,01 мοль) 2,2,5,5-τеτρамеτил-З-имидазοлин-З-οκсид-Ι-οκ- 35 сила в 3,9 мл (0,05 мοль) эτижзοцианаτа в τечение 10 ча- сοв πρи τемπеρаτуρе 50°0. Пοлучаюτ 0,75 г целевοгο προ- дуκτа. Βыχοд 41 . Τ.πл. Ι54-Ι55°σ (эφиρ) Ηайденο, $: 058,3; Η 9,8; Ν 22,5. \νθ 91/11439 ΡСΤ/δШΟ/00026Received 2,2,5,5-tetamethyl-4- (ethylamine) -3-imidazole-l-hydroxyl under the condition of the type I πp and aging 1.57 g (0.01 mol) 2,2,5,5- tetramethyl-3-imidazoline-3-oxide-Ι-οκ- 35 force of 3.9 ml (0.05 mol) of etizocyanate for 10 hours at a temperature of 50 ° 0. 0.75 g of the intended product are obtained. Likewise 41. Τ.π. Ι54-Ι55 ° σ (eφиρ) Found, $: 058.3; Η 9.8; Ν 22.5. \ νθ 91/11439 ΡСΤ / δШΟ / 00026
- 8 -- 8 -
Βычисленο, : 058,7; Η 9,8; _τ22,8. σ9нΙ8ы3ο.Calculated: 058.7; Η 9.8; _τ22.8. σ 9 n Ι8 s 3 ο.
Ж-сπеκτρ (ΚΒг): 1580, 1640, 3400. УΦ-сπеκτρ 5 (эτанοл): 213 (4,08), 241 (3,22). ρΚа = 6,4. Пρимеρ 7. • Пοлучаюτ 2,2,5,5-τеτρамеτил-4-буτиламинο-3-имида- зοлин-Ι-οκсил πρи οбρабοτκе 1,57 г (0,01 мοль) 2,2,5,5- -τеτρамеτил-3-имидазοлин-З-οκсид-Ι-οκсила 5,6 мл (0,05 мοль) Ю буτижзοцианаτа в услοвияχ πρимеρа I. Пοлучаюτ 0,85 г целевοгο цροдуκτа. Βыχοд 40..Τ.πл. οκοлο 30°С. Ηайденο, $: С 61,5; Η 10,3; 1.19,6. Βычисленο, : С 62,3; Η 10,4; -119,8.W-section (ΚΒг): 1580, 1640, 3400. W-section 5 (ethanol): 213 (4.08), 241 (3.22). ρΚ a = 6.4. Example 7. • Received 2,2,5,5-tetramethyl-4-butylamine-3-imidazoline-Ι-hydroxyl and processing 1.57 g (0.01 mol) 2,2,5,5--melt -3-imidazoline-3-oxide-Ι-oxyl 5.6 ml (0.05 mol) of the U-bisocyanate under condition I. Receive 0.85 g of the target product. Week 40 .. Τ.π. about 30 ° C. Found, $: C 61.5; Η 10.3; 1.19.6. Calculated: C 62.3; Η 10.4; -119.8.
СΙΙΗ22Ν3°- 15 ИΚ-сπеκτρ (ΚΒг): 1580, 1640, 3400. УΦ-сπеκτρ (эτанοл): 240 (3,25). ρΚа = 6,6. Пρимеρ 8. С ΙΙ Ν 22 Ν 3 ° - 15 IΚ-secectρ (ΚΒг): 1580, 1640, 3400. For Φ-secectρ (ethanol): 240 (3.25). ρΚ a = 6.6. Example 8.
Пοлучаюτ 2,2,5,5-τеτρамеτил-4-(2-χлορэτил)-аминο-3- имидазοлин-Ι-οκсил πρи οбρабοτκе 1,57 г (0,01 мοль) 20 2,2,5,5-τеτρамеτил-З-имидазοлин-З-οκсид-Ι-οκсила, 4,3 мл (0,05 мοль) 2-χлορэτижзοцианаτοм в услοвияχ πρимеρа I. Гидροжз ιщьслοаддуκτа цροвοдяτ ρасτвοροм едκοгο наτρа πρи мοльнοм сοοτнοшении 1:2. Пοлучаюτ ' 1,09 г целевοгο προдуκτа. Βыχοд 50$. Τ.πл. Ι78-Ι80°С 25 (геκсан-эτилацеτаτ 5:1).Received 2,2,5,5-tetamethyl-4- (2-chloroethyl) -amine-3-imidazoline-Ι-oxyl and processing 1.57 g (0.01 mol) 20 2,2,5,5-tetametil -Z-imidazoline-Z-oxide-Ι-oxyla, 4.3 ml (0.05 mol) 2-solution under conditions of I. Hydraulic equipment for the production of food Received '1.09 g of the target product. Βыχοд 50 $. Τ.π. Ι78-Ι80 ° С 25 (hexane-ethyl acetate 5: 1).
Ηайденο, $: С 45,6; Η 6,7; и 16,2. Βычисленο, $: 045,7; Η 6,5; ы 16,0.Found, $: C 45.6; Η 6.7; and 16.2. Calculated, $: 045.7; Η 6.5; s 16.0.
С9ΗΙ7¥С1 Ж-сπеκτρ (ΚΒг): 1550, 1640, 3380. УΦ-сπеκτρ 30 (Эτанοл): 210 (4,00). ρΚа = 5,6. С 9 Η Ι7 ¥ С1 Ж-secrete (ΚΒг): 1550, 1640, 3380. UΦ-specific 30 (Ethanol): 210 (4.00). ρΚ a = 5.6.
Заявляемые сοединения исπыτыважсь в κачесτве ρΗ чувсτвиτельныχ сπинοвыχ зοндοв и меτοκ. Для эτοгο οггρе- делялась сπеκτρальная κοнсτанτа связывания наπρимеρ, 2,2,5,5-τеτρамеτил-4-(Ι-наφτил)аминο-3-имидазοлин-Ι-οκ- 35 сила с миκροсοмальными циτοχροмοм Ρ-450.The inventive compounds were tested in sensitive quantities of sensitive blue probes and tags. For this purpose, the spectral binding constant of, for example, 2,2,5,5-tetramethyl-4- (на-naphthyl) amine-3-imidazoline-Ι-οκ-35 strength with a minimum of 450 cyme was shared.
Уκазаннοе сοединение πρи πρибавлении κ индуциροван- ным φенοбаρбиτалοм миκροсοмам ποκазываеτ на ЭПΡ-сπеκτρο- 39 - 9 - ΡСТ/δШΟ/00026The indicated compound and addition to the induced phenom enum are shown in the EPΡ-experiment 39 - 9 - ΡСТ / δШΟ / 00026
меτρе диφφеρенциаяьные сπеκτρы связывания, χаρаκτеρные дяя субсτρаτοв циτοχροма Ρ-450 с ниτροκсильным ρадиκа- лοм. Пρи οбρабοτκе κлеτοκ ορганизмοв заявляемыми сοеди- нениями наблюдалοсь изменение сπеκτρальныχ χаρаκτеρис- τиκ в сπеκτρаχ ЭПΡ. Эτο дοκазываеτ, чτο заявляемые сοе- динения сποсοбны προниκаτь чеρе.з κлеτοчные мембρаны и мοгуτ быτь исποльзοваны в κачесτве ρΗ чувсτвиτельныχ сπинοвыχ зοндοв.the method of differential binding processes, characteristic of the substrate of the Ρ-450 cytochem with a neutral radical. When processing the cells of the organisms of the claimed compounds, a change in the spectral characteristics of the electronic components was observed. This proves that the claimed connections are able to be accessed through the cell membranes and can be used in the case of sensible blue probes.
Пροмышленная πρименимοсτьIntended use
Заявляемые вещесτва мοгуτ быτь исποльзοваны в χимии в κачесτве анτиοκсиданτοв и анτисτаρиτелей и в мοлеκуляρ- нοй биοлοгии и медицине в κачесτве ρΗ чувсτвиτельныχ сπи- нοвыχ зοндοв и меτοκ. The inventive materials may be used in chemistry as antioxidants and drugs, and in biology and medicine as susceptible substances.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SU1990/000026 WO1991011439A1 (en) | 1990-01-24 | 1990-01-24 | Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SU1990/000026 WO1991011439A1 (en) | 1990-01-24 | 1990-01-24 | Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1991011439A1 true WO1991011439A1 (en) | 1991-08-08 |
Family
ID=21617647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SU1990/000026 Ceased WO1991011439A1 (en) | 1990-01-24 | 1990-01-24 | Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1991011439A1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU397516A1 (en) * | 1971-03-15 | 1973-09-17 | ||
| SU412193A1 (en) * | 1971-04-05 | 1974-01-25 | ||
| SU420627A1 (en) * | 1971-05-03 | 1974-03-25 | Л. Б. Володарский , Т. К. Севасть нова | Method of producing derivatives of 2,2,5,5-tetra-substituted 3-imidazoline-1-oxyls |
| US3927019A (en) * | 1971-02-22 | 1975-12-16 | Synvar Ass | 1-Oxylimidazolinyl compounds used as stable free radical pH indicators |
| US4328349A (en) * | 1980-10-08 | 1982-05-04 | Sk&F Lab Co. | Process for preparing 5-methyl-4-imidazolecarboxylic acid esters |
-
1990
- 1990-01-24 WO PCT/SU1990/000026 patent/WO1991011439A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3927019A (en) * | 1971-02-22 | 1975-12-16 | Synvar Ass | 1-Oxylimidazolinyl compounds used as stable free radical pH indicators |
| SU397516A1 (en) * | 1971-03-15 | 1973-09-17 | ||
| SU412193A1 (en) * | 1971-04-05 | 1974-01-25 | ||
| SU420627A1 (en) * | 1971-05-03 | 1974-03-25 | Л. Б. Володарский , Т. К. Севасть нова | Method of producing derivatives of 2,2,5,5-tetra-substituted 3-imidazoline-1-oxyls |
| US4328349A (en) * | 1980-10-08 | 1982-05-04 | Sk&F Lab Co. | Process for preparing 5-methyl-4-imidazolecarboxylic acid esters |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trevino et al. | Acetoacetylated castor oil in coatings applications | |
| Kanaoka et al. | Fluorescent thiol reagents. VI: N-(1-Anilinonaphthyl-4) maleimide; a fluorescent hydrophobic probe directed to thiol groups in protein | |
| Nie et al. | Modified hydrazone derivatives for ratiometric and colorimetric F− recognition: Relationship between architectures and performances | |
| CN106478602B (en) | A kind of colorimetric probe and the preparation method and application thereof based on naphthalimide derivative | |
| CN110759833A (en) | Preparation method and application of 4-hydroxy-benzyl (2' -hydroxy-benzylidene) -hydrazide | |
| WO1991011439A1 (en) | Derivatives of 4-amino-3-imidazoline-1-oxyl and method of preparation | |
| CN113788850B (en) | Melamine metal compound and preparation method thereof | |
| Făgădar-Cosma et al. | Synthesis, characterization and correlative biological effects in wheat of a benzoxaza-and a diaza-phosphorus (V) heterocycles | |
| Fernández-Alonso et al. | Solid fluorescence sensors obtained by functionalization of photocrosslinked water-swollen acrylic membranes with 4-piperazine naphthalimide derivatives | |
| EP0547736A1 (en) | Process for the preparation of 1-n-acetyl-3,5,7-trinitro-cyclotetramethylenetetramine | |
| Garssen et al. | NMR studies of the interaction of gene-V protein of bacteriophage M13 with oligonucleotides | |
| AU673593B2 (en) | 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same | |
| RU2248353C2 (en) | Method for preparing 3-methyl-1,2,4-triazolyl-5-thioacetate morpholinium | |
| US6582952B1 (en) | Method for eliminating a nitrogenated heterocyclic, or aromatic, compound in an effluent | |
| Morisaki et al. | Synthesis of optically active oligomers consisting of chiral phosphorus atoms: capture of an intermediate between a polymer and a small molecule | |
| CN114031532A (en) | Thiourea-modified pyrene derivative fluorescent probe and preparation method and application thereof | |
| JP7076565B2 (en) | Salt form, crystalline form and method for producing the compound used as an FGFR4 inhibitor. | |
| Výprachtický et al. | A novel three-step synthesis of N-(2-ethylhexyl)-2, 7-diiodocarbazole | |
| CN110724144A (en) | Pyrazolidone impurity, preparation method and application | |
| JP2993856B2 (en) | Method for producing carbazic acid | |
| JPH0741495A (en) | 14alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and its production | |
| US5116994A (en) | Deacylating agent and deacylating method | |
| RU2017742C1 (en) | Method of synthesis of 5,15-di(p-nitrophenyl)-3,7,13,17-tetramethyl- 2,8,12,18-tetrabutylporphin | |
| Kim et al. | Interaction of crosslinked poly (4‐vinylpyridine) with methyl orange | |
| US4097488A (en) | N-(3-fluoranthyl)maleimide; a fluorescent reagent for the studies of thiol compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CH DE GB JP US |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |